We are live on ! Find out more
TRIV

TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV

Delisted

TRIV was delisted on the 3rd of February, 2016.

41 hedge funds and large institutions have $181M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

17% more funds holding

Funds holding: 3541 (+6)

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

1% less capital invested

Capital invested by funds: $184M → $181M (-$2.51M)

Holders
41
Holders Change
+6
Holders Change %
+17.14%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
10
Increased
13
Reduced
12
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$57.1M
MAM
2
MPM Asset Management
Massachusetts
$25.7M
RG
3
Redmile Group
California
$25.5M +$3.06M +210,870 +14%
DM
4
Deerfield Management
New York
$22.2M +$724K +49,865 +3%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$21.4M +$223K +15,389 +1%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$9.15M +$365K +25,130 +4%
Stifel Financial
7
Stifel Financial
Missouri
$5.16M
BFA
8
BlackRock Fund Advisors
California
$2.54M +$2.55M +175,553 New
DCM
9
Driehaus Capital Management
Illinois
$1.84M -$289K -19,940 -14%
JP Morgan Chase
10
JP Morgan Chase
New York
$1.74M -$1.03M -71,175 -37%
Allianz Asset Management
11
Allianz Asset Management
Germany
$1.12M +$1.12M +77,200 New
Northern Trust
12
Northern Trust
Illinois
$1.06M +$812K +55,970 +318%
BIT
13
BlackRock Institutional Trust
California
$928K +$930K +64,065 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$877K +$79.8K +5,496 +10%
USAA
15
United Services Automobile Association
Texas
$851K +$54.4K +3,750 +7%
Goldman Sachs
16
Goldman Sachs
New York
$666K +$53.7K +3,701 +9%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$462K +$24.2K +1,667 +6%
BCM
18
Bridgeway Capital Management
Texas
$436K +$437K +30,100 New
TCIM
19
TIAA CREF Investment Management
New York
$382K
Bank of New York Mellon
20
Bank of New York Mellon
New York
$374K -$581 -40 -0.2%
State Street
21
State Street
Massachusetts
$315K +$122K +8,429 +63%
BIM
22
BlackRock Investment Management
Delaware
$315K +$316K +21,760 New
Millennium Management
23
Millennium Management
New York
$257K -$259K -17,860 -50%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$198K +$1.13K +78 +0.6%
Charles Schwab
25
Charles Schwab
California
$158K

TRIV Hedge Fund Activity: Q3 2014 in Review

41 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q3 2014, worth a combined $181M — down 1.4% from $184M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TRIV positions and 4 closed out — a net gain of 6 holders — while 13 added to existing stakes and 12 trimmed.

The largest buyer was Redmile Group, adding an estimated $3.06M. The largest seller was JP Morgan Chase, cutting an estimated $1.03M.

  • 41 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q3 2014, up from 35 in Q2 2014.
  • Funds reported $181M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q3 2014, down 1.4% quarter-over-quarter.
  • 10 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q3 2014 and 4 closed out, a net change of +6 holders.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q3 2014 was Redmile Group, an estimated $3.06M added.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q3 2014 was JP Morgan Chase, an estimated $1.03M sold.

Based on aggregated 13F filings for Q3 2014.